Drugs / M254
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03866577 | Dec 2018 → Jun 2021 | autoimmune thrombocytopenic purpura | Momenta Pharmaceuticals, Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | M254 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03866577 ↗ |
| Route | Intravenous | “M254 administered as intravenous infusion” NCT03866577 ↗ |